JP2013544268A5 - - Google Patents

Download PDF

Info

Publication number
JP2013544268A5
JP2013544268A5 JP2013541333A JP2013541333A JP2013544268A5 JP 2013544268 A5 JP2013544268 A5 JP 2013544268A5 JP 2013541333 A JP2013541333 A JP 2013541333A JP 2013541333 A JP2013541333 A JP 2013541333A JP 2013544268 A5 JP2013544268 A5 JP 2013544268A5
Authority
JP
Japan
Prior art keywords
alkyl
group
groups
cycloalkyl
heteroatoms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013541333A
Other languages
English (en)
Japanese (ja)
Other versions
JP5853317B2 (ja
JP2013544268A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2011/071410 external-priority patent/WO2012072691A1/en
Publication of JP2013544268A publication Critical patent/JP2013544268A/ja
Publication of JP2013544268A5 publication Critical patent/JP2013544268A5/ja
Application granted granted Critical
Publication of JP5853317B2 publication Critical patent/JP5853317B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013541333A 2010-12-01 2011-11-30 インダニルオキシジヒドロベンゾフラニル酢酸 Expired - Fee Related JP5853317B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
EP10193382 2010-12-01
EP10193382.8 2010-12-01
EP11154999.4 2011-02-18
EP11154999 2011-02-18
EP11175646.6 2011-07-27
EP11175646 2011-07-27
PCT/EP2011/071410 WO2012072691A1 (en) 2010-12-01 2011-11-30 Indanyloxydihydrobenzofuranylacetic acids

Publications (3)

Publication Number Publication Date
JP2013544268A JP2013544268A (ja) 2013-12-12
JP2013544268A5 true JP2013544268A5 (OSRAM) 2015-01-22
JP5853317B2 JP5853317B2 (ja) 2016-02-09

Family

ID=45063142

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013541333A Expired - Fee Related JP5853317B2 (ja) 2010-12-01 2011-11-30 インダニルオキシジヒドロベンゾフラニル酢酸

Country Status (10)

Country Link
US (1) US20120302566A1 (OSRAM)
EP (1) EP2646425B1 (OSRAM)
JP (1) JP5853317B2 (OSRAM)
AR (1) AR084050A1 (OSRAM)
DK (1) DK2646425T3 (OSRAM)
ES (1) ES2546154T3 (OSRAM)
HU (1) HUE025363T2 (OSRAM)
PL (1) PL2646425T3 (OSRAM)
UY (1) UY33758A (OSRAM)
WO (1) WO2012072691A1 (OSRAM)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8642585B2 (en) * 2012-03-26 2014-02-04 Boehringer Ingelheim International Gmbh Indanyloxydihydrobenzofuranylacetic acids
US8809376B2 (en) * 2012-04-30 2014-08-19 Boehringer Ingelheim International Gmbh Indanyloxydihydrobenzofuranylacetic acids
CA2878625A1 (en) 2012-07-11 2014-01-16 Elcelyx Therapeutics, Inc. Compositions comprising statins, biguanides and further agents for reducing cardiometabolic risk
BR112015009376A2 (pt) * 2012-11-28 2017-07-04 Boehringer Ingelheim Int ácidos indaniloxidihidrobenzofuranilacéticos
WO2014086712A1 (en) 2012-12-07 2014-06-12 Boehringer Ingelheim International Gmbh New indanyloxydihydrobenzofuranylacetic acids
EP2953681B1 (en) 2013-02-06 2017-03-15 Boehringer Ingelheim International GmbH New indanyloxydihydrobenzofuranylacetic acids
RU2015140066A (ru) 2013-02-22 2017-03-30 Мерк Шарп И Доум Корп. Противодиабетические бициклические соединения
WO2015024526A1 (en) * 2013-08-23 2015-02-26 Fujian Haixi Pharmaceuticals Co., Ltd Carboxylic acid compounds in treatment of diabetes mellitus
JP6533778B2 (ja) * 2013-09-26 2019-06-19 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Gpr40アゴニストとしてのインダニルオキシジヒドロベンゾフラニル酢酸誘導体を調製するための方法および中間体
ES2747973T3 (es) 2013-11-15 2020-03-12 Merck Sharp & Dohme Compuestos tricíclicos antidiabéticos
JP6441928B2 (ja) * 2013-11-28 2018-12-19 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規インダニルオキシフェニルシクロプロパンカルボン酸
US9957219B2 (en) 2013-12-04 2018-05-01 Merck Sharp & Dohme Corp. Antidiabetic bicyclic compounds
US10059667B2 (en) 2014-02-06 2018-08-28 Merck Sharp & Dohme Corp. Antidiabetic compounds
CN105001212B (zh) * 2014-04-16 2018-01-16 江苏柯菲平医药股份有限公司 稠环化合物及其制备方法和应用
WO2015176267A1 (en) 2014-05-22 2015-11-26 Merck Sharp & Dohme Corp. Antidiabetic tricyclic compounds
WO2016022446A1 (en) 2014-08-08 2016-02-11 Merck Sharp & Dohme Corp. [5,6]-fused bicyclic antidiabetic compounds
WO2016022448A1 (en) 2014-08-08 2016-02-11 Merck Sharp & Dohme Corp. Antidiabetic bicyclic compounds
WO2016019587A1 (en) 2014-08-08 2016-02-11 Merck Sharp & Dohme Corp. [7, 6]-fused bicyclic antidiabetic compounds
US10968193B2 (en) 2014-08-08 2021-04-06 Merck Sharp & Dohme Corp. Antidiabetic bicyclic compounds
CN104177320B (zh) * 2014-08-27 2016-03-02 广东东阳光药业有限公司 一种脲取代联苯类化合物及其组合物及用途
WO2017172505A1 (en) 2016-03-29 2017-10-05 Merck Sharp & Dohme Corp. Antidiabetic bicyclic compounds
US11072602B2 (en) 2016-12-06 2021-07-27 Merck Sharp & Dohme Corp. Antidiabetic heterocyclic compounds
KR102007633B1 (ko) * 2016-12-15 2019-08-06 일동제약(주) 신규 페닐 프로피온 산 유도체 및 이의 용도
WO2018118670A1 (en) 2016-12-20 2018-06-28 Merck Sharp & Dohme Corp. Antidiabetic spirochroman compounds
CN110248929B (zh) 2017-01-26 2023-05-12 勃林格殷格翰国际有限公司 苄基氨基吡嗪基环丙烷甲酸、其药物组合物和用途
US10913720B2 (en) 2017-01-26 2021-02-09 Boehringer Ingelheim International Gmbh Benzyloxypyridylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof
US10603317B2 (en) 2017-01-26 2020-03-31 Boehringer Ingelheim International Gmbh Benzylaminopyridylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof
US10919859B2 (en) 2017-01-26 2021-02-16 Boehringer Ingelheim International Gmbh Benzylaminopyridylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof
CN110300755B (zh) * 2017-02-08 2022-10-04 勃林格殷格翰国际有限公司 茚满基氨基氮杂二氢苯并呋喃乙酸、用于治疗糖尿病的药物组合物
US11225471B2 (en) 2017-11-16 2022-01-18 Merck Sharp & Dohme Corp. Antidiabetic bicyclic compounds
CN111712494A (zh) 2018-02-13 2020-09-25 吉利德科学公司 Pd-1/pd-l1抑制剂
EP4600247A3 (en) 2018-04-19 2025-11-19 Gilead Sciences, Inc. Pd-1/pd-l1 inhibitors
KR20230159715A (ko) 2018-07-13 2023-11-21 길리애드 사이언시즈, 인코포레이티드 Pd-1/pd-l1 억제제
AU2019366355B2 (en) 2018-10-24 2022-10-13 Gilead Sciences, Inc. PD-1/PD-L1 inhibitors
WO2021071837A1 (en) 2019-10-07 2021-04-15 Kallyope, Inc. Gpr119 agonists
BR112022017039A2 (pt) 2020-02-28 2022-11-16 Kallyope Inc Agonistas de gpr40
JP2023526625A (ja) 2020-05-19 2023-06-22 キャリーオペ,インク. Ampkアクチベーター
CN116390925A (zh) 2020-06-26 2023-07-04 卡尔优普公司 Ampk活化剂
TW202317542A (zh) * 2021-06-23 2023-05-01 美商纜圖藥品公司 製備egfr抑制劑的方法
WO2025140655A1 (en) * 2023-12-30 2025-07-03 Fujian Haixi Pharmaceuticals Co., Ltd. Heteroaryl compounds as multi-target protein kinase inhibitors

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2628103B1 (fr) 1988-03-03 1991-06-14 Roussel Uclaf Nouveaux esters pyrethrinoides portant un noyau indanyle, leur procede de preparation et leur application comme pesticides
US7960369B2 (en) 2002-11-08 2011-06-14 Takeda Pharmaceutical Company Limited Receptor function regulator
JP4594611B2 (ja) * 2002-11-08 2010-12-08 武田薬品工業株式会社 受容体機能調節剤
JP4805552B2 (ja) * 2003-05-30 2011-11-02 武田薬品工業株式会社 縮合環化合物
EP1833859A2 (en) 2004-12-16 2007-09-19 ExxonMobil Chemical Patents Inc. Halogen substituted metallocene compounds for olefin polymerization
EP1924546A1 (en) * 2005-09-14 2008-05-28 Amgen, Inc Conformationally constrained 3- (4-hydroxy-phenyl) - substituted-propanoic acids useful for treating metabolic disorders
MX2008012529A (es) * 2006-03-30 2008-10-14 Asahi Kasei Pharma Corp Derivado biciclico substituido y uso del mismo.
JP4401428B2 (ja) 2006-06-27 2010-01-20 武田薬品工業株式会社 縮合環化合物
WO2008054675A2 (en) * 2006-10-31 2008-05-08 Merck & Co., Inc. Antidiabetic bicyclic compounds
EP2289868B1 (en) * 2008-06-25 2014-08-13 Daiichi Sankyo Company, Limited Carboxylic acid compound
ES2450567T3 (es) * 2008-10-15 2014-03-25 Amgen, Inc Moduladores de GPR40 espirocíclicos
WO2010143733A1 (en) * 2009-06-09 2010-12-16 Takeda Pharmaceutical Company Limited Novel fused cyclic compound and use thereof
US8642585B2 (en) * 2012-03-26 2014-02-04 Boehringer Ingelheim International Gmbh Indanyloxydihydrobenzofuranylacetic acids

Similar Documents

Publication Publication Date Title
JP2013544268A5 (OSRAM)
ES2580481T3 (es) Derivados de aminoquinazolina y sus sales, y métodos de uso
JP6603649B2 (ja) キヌレニン経路の阻害剤
WO2009095872A3 (en) Labelled analogues of halobenzamides as multimodal radiopharmaceuticals and their precursors
JP2013505946A5 (OSRAM)
JP2015501833A5 (OSRAM)
MX2015015893A (es) 2-fenilimidazo[1,2-a]pirimidinas como agentes formadores de imagen.
JP2020505393A5 (OSRAM)
JP2014511892A5 (OSRAM)
AR072906A1 (es) Nucleosidos modificados utiles como antivirales
HRP20170450T1 (hr) Prstenaste n,n′-diariltiouree i n,n′-diariluree kao antagonisti androgenskog receptora, sredstvo protiv raka, postupak njihovog dobivanja i njihove upotrebe
AR064608A1 (es) Derivados de pirazolo-quinazolina sustituidos, composiciones farmaceuticas que los contienen. proceso para su preparacion y uso de los mismos como agentes anticancer.
JP2018535963A5 (OSRAM)
AR084370A1 (es) Derivados de aminopirazol
AR082519A1 (es) Fenilamidinas que tienen alta actividad fungicida, y su utilizacion
JP2015523339A5 (OSRAM)
JP2020505400A5 (OSRAM)
RU2009106866A (ru) Спирокетальное производное с конденсированными кольцами и его применение в качестве противодиабетического лекарственного средства
JP2015504091A5 (OSRAM)
JP2016508506A5 (OSRAM)
PH12015501226A1 (en) Crystalline 6,7-unsaturated-7-carbamoyl morphinane derivative, and method for producing the same
JP2011506501A5 (OSRAM)
CA2709776A1 (en) Substituted pyrrolo[2, 3-b] and pyrazolo[3, 4-b] pyridines for use as adenosine receptor ligands
JP2019535792A5 (OSRAM)
TW201121959A (en) Sigma ligands for the prevention or treatment of pain induced by chemotherapy